Autoinflammatory disorders

Gene: PSMB9

Green List (high evidence)

PSMB9 (proteasome subunit beta 9)
EnsemblGeneIds (GRCh38): ENSG00000240065
EnsemblGeneIds (GRCh37): ENSG00000240065
OMIM: 177045, Gene2Phenotype
PSMB9 is in 3 panels

1 review

Arina Puzriakova (Genomics England Curator)

Green List (high evidence)

This gene has been confirmed for this panel by the NHS Genomic Medicine Service and should be rated green.
Created: 16 Feb 2022, 11:44 a.m. | Last Modified: 16 Feb 2022, 11:44 a.m.
Panel Version: 0.36
Comment on mode of inheritance: Updated MOI from biallelic to monoallelic as all cases reported to date have harboured heterozygous variants in this gene (PMID: 26524591; 33727065; 34819510)
Created: 11 Jan 2022, 2:09 p.m. | Last Modified: 11 Jan 2022, 2:09 p.m.
Panel Version: 0.6
PSMB9 is rated Amber on the PID panel (R15, version 2.524) and the OMIM entry for this phenotype (MIM# 617591) is currently set to provisional.

Brehm et al., 2015 (PMID: 26524591) describe a Jamaican family with two affected sibs who harboured digenic heterozygous variants in the PSMB4 (c.44insG/p.P16Sfs*45) and PSMB9 (c.494G>A/p.G165D) genes that were identified by targeted screening of proteasome candidate genes. Both had a clinical phenotype of CANDLE syndrome.

Kataoka et al., 2021 (PMID: 33727065) reported a de novo PSMB9 variant (c.467G>A/p.G156D) in a 1-month old Japanese boy who developed fever, a chilblain-like skin rash, myositis, and severe pulmonary hypertension due to the hyperactivation of IFN-α. In vitro experiments using patient-derived primary cells and cell lines transduced with the mutant gene revealed reduced proteasome activities. The patient responded to treatment with a Janus kinase inhibitor, tofacitinib, and later received stem cell transplantation - following which he no longer required tofacitinib and experienced no disease recurrence.

Kanazawa et al., 2021 (PMID: 34819510) identified a further two unrelated Japanese patients with the same de novo PSMB9 heterozygous missense variant as that identified in the previous study (c.467G>A/p.G156D). Both individuals displayed severe autoinflammatory phenotypes and pulmonary hypertension and later also manifested combined immunodeficiency with periodic inflammatory exacerbation. The variant lead to impaired immunoproteasome maturation and activity, and the proteasome defect and immunodeficient phenotypes were recapitulated in Psmb9(G156D/+) mice.
Created: 11 Jan 2022, 2:06 p.m. | Last Modified: 11 Jan 2022, 2:06 p.m.
Panel Version: 0.4

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Proteasome-associated autoinflammatory syndrome 3, digenic, OMIM:617591

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Green
  • NHS GMS
Phenotypes
  • CANDLE syndrome (Autoinflammation, lipodystrophy, and dermatosis syndrome)
  • Proteasome-associated autoinflammatory syndrome 3, digenic, OMIM:617591
Tags
digenic
OMIM
177045
Clinvar variants
Variants in PSMB9
Penetrance
None
Publications
Panels with this gene

History Filter Activity

2 Mar 2022, Gel status: 3

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag digenic tag was added to gene: PSMB9.

16 Feb 2022, Gel status: 3

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: psmb9 has been classified as Green List (High Evidence).

19 Jan 2022, Gel status: 2

Added New Source

Arina Puzriakova (Genomics England Curator)

Source NHS GMS was added to PSMB9.

11 Jan 2022, Gel status: 2

Set mode of inheritance

Arina Puzriakova (Genomics England Curator)

Mode of inheritance for gene: PSMB9 was changed from BIALLELIC, autosomal or pseudoautosomal to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

11 Jan 2022, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: PSMB9 were set to 26524591; 33727065

11 Jan 2022, Gel status: 2

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Arina Puzriakova (Genomics England Curator)

gene: PSMB9 was added gene: PSMB9 was added to Autoinflammatory disorders. Sources: Expert Review Amber Mode of inheritance for gene: PSMB9 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: PSMB9 were set to 26524591; 33727065 Phenotypes for gene: PSMB9 were set to CANDLE syndrome (Autoinflammation, lipodystrophy, and dermatosis syndrome); Proteasome-associated autoinflammatory syndrome 3, digenic, OMIM:617591